Avenue Therapeutics Inc (ATXI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3620 +0.0070 (+1.97%) 03/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3620 unch (unch) 15:53 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 14,540 | 8,043 | 3,738 | 5,213 | 26,265 |
| Operating Income | -14,540 | -8,043 | -3,738 | -5,213 | -26,265 |
| Other Income | 4,052 | 4,440 | 7 | 62 | 357 |
| Pre-tax Income | -10,488 | -3,603 | -3,731 | -5,151 | -25,908 |
| Net Income Continuous | -10,488 | -3,603 | -3,731 | -5,151 | -25,908 |
| Minority Interests | -111 | -51 | N/A | N/A | N/A |
| Net Income | $-10,377 | $-3,552 | $-3,731 | $-5,151 | $-25,908 |
| EPS Basic Total Ops | -73.68 | -122.56 | -247.37 | -349.45 | -1,859.97 |
| EPS Basic Continuous Ops | -74.45 | -123.98 | -247.60 | -351.78 | -1,857.59 |
| EPS Diluted Total Ops | -73.68 | -122.56 | -247.37 | -349.45 | -1,859.97 |
| EPS Diluted Continuous Ops | -74.45 | -123.98 | -247.60 | -351.78 | -1,857.59 |
| EPS Diluted Before Non-Recurring Items | -73.68 | -122.56 | -248.00 | -349.45 | -1,859.97 |
| EBITDA(a) | $-14,540 | $-8,043 | $-3,738 | $-5,213 | $-26,265 |